ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

RFA, “New Approaches In Surgical Oncology” Announced By DCT

December 1, 1978

Society Support Program for Training Cytotechnologists

November 29, 1991

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

February 22, 1980

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990